Scholar Rock Holding Corp. (NASDAQ:SRRK) is one of the best multibagger stocks to invest in right now. The company’s stock’s performance was largely supported by optimism around its lead drug candidate, apitegromab. The stock surged nearly sixfold in 2024, but as the company approaches a potential U.S. market launch in Q3 2025, volatility has increased. Shares are down approximately 25% year-to-date, although market sentiment remains highly positive, with a consensus Buy rating. Why is apitegromab viewed ...